We enrolled 1147 HIV-negative individuals in long-term serodiscordant relationships at 3 sites in Uganda from the Partners Pre-exposure Prophylaxis Study , a randomized placebo-controlled trial of daily oral tenofovir and emtricitabine/tenofovir .